Podcasts about diagnostic

Dr Laura Adang returns to the podcast, this time discussing diagnostic delays in early onset forms of metachromatic leukodystrophy and explains why the only logical route to prompt diagnosis is newborn screening and how gene therapy might lead to a 'normal' life for children, if only we can find them early enough. Characterizing Diagnostic Delays in Metachromatic Leukodystrophy: A Real-World Data Approach Ali Mohajer, et al https://doi.org/10.1002/jimd.70049

Alliance Maladies Rares & RARE à l'écoute  Chaque mois, RARE à l'écoute et l'Alliance Maladies Rares s'associent pour mettre en lumière les défis, les avancées et les initiatives qui peuvent changer la vie des 3 millions de Français concernés par une maladie rare. Pour ce sixième épisode, Maryse Leleu, présidente de l'association Ouvrir les Yeux et membre active de nombreuses instances nationales de recherche et de représentation des patients, partage une vision prospective : Que peut-on espérer, et que faut-il redouter, pour les personnes concernées par une maladie rare à l'horizon 2050 ? Au programme de cet épisode : Les promesses de la génétique, des biothérapies et de la médecine de précision. L'espoir d'un diagnostic plus rapide, plus précis et accessible à tous. Les risques d'inégalités dans l'accès aux traitements et à l'innovation. Les enjeux éthiques autour des données et de l'intelligence artificielle. Une conviction forte : l'avenir sera meilleur grâce à l'engagement obstiné des acteurs associatifs. Cet épisode nous invite à imaginer un avenir où chaque malade rare pourrait être mieux diagnostiqué, mieux soigné et mieux accompagné.    Invitée : Maryse Leleu, présidente d'Ouvrir les Yeux, membre du Conseil national de l'Alliance Maladies Rares, co-animatrice de la commission Recherche de l'Alliance, membre du GRAM Inserm, membre du conseil scientifique de la Fondation Maladies Rares. https://www.ouvrirlesyeux.org/fr/ https://alliance-maladies-rares.org/ https://www.inserm.fr/ https://fondation-maladiesrares.org/ L'équipe : Virginie Druenne - Programmation Cyril Cassard - Animation Hervé Guillot - Production Crédits : Sonacom **************************************************** Alliance maladies rares, association reconnue d'utilité publique, est un collectif qui rassemble 240 associations de personnes malades et de parents. Elle porte la voix de 3 millions de Français concernés par 7000 maladies rares. Ses missions principales sont de porter la voix des malades auprès des pouvoirs publics ; d'accompagner, de former et d'informer les associations de malades ; de sensibiliser les professionnels de santé et le grand public aux maladies rares.

Chad Schnitz, Vice President of TOPDON, joins Holman on this episode of the podcast to talk about technician and prosumer diagnostic tools, right to repair, and the future of automotive repair and modification in the era of advanced computers and electrification. The Truck Show Podcast is produced in partnership with AMSOIL, Kershaw Knives, UEM Pistons, and OVR Mag.

Si l'intelligence artificielle suscite autant d'espoir que de craintes, il y a un domaine dans lequel elle fait largement consensus, c'est celui de la santé. En particulier en radiologie. Reportage en Suède.  Cette émission est une réédition estivale de nos programmes   IA et santé En Suède, chaque année, environ 8 000 femmes sont touchées par le cancer du sein. Il est crucial pour leur survie que la maladie soit prise de vitesse et détectée le plus tôt possible. À Stockholm, l'Hôpital Capio St Göran a acquis une grande popularité : il est le tout premier au monde à avoir utilisé l'intelligence artificielle pour le dépistage du cancer du sein, et les résultats sont probants. Reportage, Ottilia Ferey. Les métiers de l'interprétariat et de la traduction sont-ils menacés par l'intelligence artificielle ? Les logiciels de traitement du langage existent depuis de nombreuses années, mais ils ont atteint un niveau de performance qui peut inquiéter les professionnels. À Genève dans les agences de l'ONU, les interprètes de conférence se demandent s'ils et elles seront un jour remplacé-es par des machines. Jérémie Lanche.   Le choix musical de Vincent Théval : Deriya Yildirim et Group Cimcek, Achiyor.   À Tirana, la nouvelle vie de la villa du dictateur L'Albanie, bientôt membre de l'Union européenne ? Le rapprochement se poursuit en tout cas avec ce pays profondément marqué par la dictature d'Enver Hoxha. Un sinistre demi-siècle dont l'exploration n'est pas terminée ; mais, signe que les choses évoluent, la villa du dictateur stalinien est aujourd'hui une résidence d'artistes. À Tirana, le reportage de Louis Seiller.  

Si l'intelligence artificielle suscite autant d'espoir que de craintes, il y a un domaine dans lequel elle fait largement consensus, c'est celui de la santé. En particulier en radiologie. Reportage en Suède.  Cette émission est une réédition estivale de nos programmes   IA et santé En Suède, chaque année, environ 8 000 femmes sont touchées par le cancer du sein. Il est crucial pour leur survie que la maladie soit prise de vitesse et détectée le plus tôt possible. À Stockholm, l'Hôpital Capio St Göran a acquis une grande popularité : il est le tout premier au monde à avoir utilisé l'intelligence artificielle pour le dépistage du cancer du sein, et les résultats sont probants. Reportage, Ottilia Ferey. Les métiers de l'interprétariat et de la traduction sont-ils menacés par l'intelligence artificielle ? Les logiciels de traitement du langage existent depuis de nombreuses années, mais ils ont atteint un niveau de performance qui peut inquiéter les professionnels. À Genève dans les agences de l'ONU, les interprètes de conférence se demandent s'ils et elles seront un jour remplacé-es par des machines. Jérémie Lanche.   Le choix musical de Vincent Théval : Deriya Yildirim et Group Cimcek, Achiyor.   À Tirana, la nouvelle vie de la villa du dictateur L'Albanie, bientôt membre de l'Union européenne ? Le rapprochement se poursuit en tout cas avec ce pays profondément marqué par la dictature d'Enver Hoxha. Un sinistre demi-siècle dont l'exploration n'est pas terminée ; mais, signe que les choses évoluent, la villa du dictateur stalinien est aujourd'hui une résidence d'artistes. À Tirana, le reportage de Louis Seiller.  

Dr. Trey Bateman and Dr. Gregg Day discuss the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care.  Show reference: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.70316 

Dr. Trey Bateman talks with Dr. Gregg Day about the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care.  Read the related article in Alzheimer's & Dementia.  Disclosures can be found at Neurology.org. 

REDIFF - "Symptômes" s'intéresse aux diagnostics complexes. Et souvent, ce qui fait un bon épisode, c'est le suspense entre le moment où le médecin découvre le symptôme et le moment où il trouve comment prendre en charge son patient. Pourtant, parfois, le doute et l'inconnu se situent tout à fait ailleurs. Les difficultés apparaissent quand démarre le traitement et c'est particulièrement le cas pour tout ce qui concerne la santé mentale. Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

5éme épisode / 5, de la série sur le DAAT.  Invité : Mr Noël André, délégué régional Normandie de l'association ADAAT Alpha1-France.  https://www.alpha1-france.org/   1️⃣   Quelles sont les circonstances de découverte du déficit en alpha-1 antitrypsine ? [0'25 – 1'34]  ✔️ Premiers signes d'essoufflement à 30 ans, interprétés à tort comme de l'asthme. ✔️ Diagnostic erroné et traitement inadapté pendant plusieurs années malgré un suivi par le médecin traitant et un pneumologue. ✔️ Dégradation progressive liée à une méconnaissance du déficit en alpha-1 antitrypsine. Pour plus d'informations, retrouvez notre page article : https://rarealecoute.com/le-deficit-en-alpha-1-antitrypsine-ou-daat/ 2️⃣   Comment s'est déroulé le diagnostic ? [1'35 – 2'30]  ✔️ Diagnostic posé par une pneumologue nouvellement installée, après des examens ciblés, dont une prise de sang. ✔️ Découverte du déficit en alpha-1 antitrypsine, maladie jusque-là inconnue. ✔️ Sentiment mêlé de soulagement (avoir enfin un diagnostic) et d'inquiétude face à l'avenir. 3️⃣   Comment s'organise la prise en charge ? [2'31 -3'01]  ✔️ Suivi régulier depuis 15 ans en CHU, en pneumologie. ✔️ État de santé stable grâce à une prise en charge spécialisée. 4️⃣   Un dépistage familial a-t-il été effectué ? [3'01 – 4'00] ✔️ Dépistage familial réalisé dès le diagnostic : trois enfants sont porteurs du déficit, sans symptômes à ce jour. ✔️ Transmission génétique identifiée, permettant une sensibilisation rapide de la famille. ✔️ Prévention mise en place précocement, notamment par l'arrêt ou l'absence de tabac. 5️⃣   Quelles sont les motivations à devenir délégué régional Normandie de l'association ADAAT Alpha1-France ? [4'01 – 4'33]  ✔️ Implication de longue date dans le milieu associatif. ✔️ Connaissance des enjeux et difficultés liés au bénévolat dans les associations. 6️⃣   Quelles sont les missions de l'association à l'échelle nationale et régionale ? [4'33 – 5'51]  ✔️ Sensibiliser professionnels de santé et familles à la maladie rare. ✔️ Soutenir les familles par des rencontres et échanges en ligne. ✔️ Organiser des actions régionales comme les cafés alpha-1 et collaborer avec l'Alliance Maladies Rares. 7️⃣   Quel message transmettre aux auditeurs ? [5'52 – 6 '30]  ✔️ Ne pas hésiter à changer de médecin si l'on sent que quelque chose ne va pas. ✔️ L'errance diagnostique est un problème majeur des maladies rares comme le déficit en alpha-1 antitrypsine insister pour obtenir un second avis et ne pas rester passif face à une évolution inquiétante.   L'équipe : Virginie Druenne – Ambassadrice RARE à l'écoute Cyril Cassard – Journaliste/Animation Hervé Guillot - Production Crédits : Sonacom ************************************************ RARE à l'écoute est le 1er média d'influence entièrement dédié aux maladies rares : - Un podcast pour faire entendre les voix de celles et ceux qui vivent, soignent et accompagnent ces maladies souvent invisibles. - Les Revues Horizon pour mettre en lumière les meilleures initiatives des centres experts, pour inspirer et connecter les professionnels de santé. - Des Lives engagés, pensés pour les patients, leurs proches et les associations. Un média indépendant, engagé et utile, au service d'un meilleur parcours de soin pour les patients atteints de maladies rares. Toutes nos ressources utiles sont accessibles gratuitement sur : www.rarealecoute.com

REDIFF - "Symptômes" s'intéresse aux diagnostics complexes. Et souvent, ce qui fait un bon épisode, c'est le suspense entre le moment où le médecin découvre le symptôme et le moment où il trouve comment prendre en charge son patient. Pourtant, parfois, le doute et l'inconnu se situent tout à fait ailleurs. Les difficultés apparaissent quand démarre le traitement et c'est particulièrement le cas pour tout ce qui concerne la santé mentale. Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

You have heard about AI everywhere, and now it is being used within EMR services. If you feel unsure about this topic or you want to learn more, then definitely play this episode and join us for the conversation! In this podcast episode, Catharine from Jane App and I discuss how Jane App incorporates AI into their EMR, including some general best practice guidelines about how you can use to use Jane's AI Script services ethically and safely in your practice.  MEET CATHARINE Catharine Martin is the Privacy and Compliance Manager at Jane App, where she plays a key leadership role in shaping and overseeing the company's privacy and regulatory strategies. With a strong background in data protection and compliance, she works closely with healthcare practitioners to ensure their practices meet evolving privacy requirements while also finding practical ways to reduce administrative burden. Beyond her work at Jane, Catharine is also a dedicated Pilates instructor, bringing the same focus and discipline to her teaching as she does to her professional work. Learn more about Catharine on her LinkedIn profile.  In this episode:  Working with Jane App  AI Scribe AI in client diagnostics  It is all up to you  Jane's appearance in The Globe and Mail  Working with Jane App Catharine, 20 years ago, after giving birth, had a radical and unexpected medical event that left her in a brief coma, experiencing multiple organ failure.  However, due to her incredible doctors, her strength, and a lot of luck, she survived and kept all her organs, without needing any transplants, and went on to make a full recovery.  How did this bring her to work for Jane App? After what Catharine went through, she felt so drawn to Jane App's vision to “Help the helpers”, that she started working for the company to further their mission.  AI Scribe Jane App offers an AI scribe feature. It essentially charts notes from your sessions with clients in your own voice.  Jane secured a third-party vendor who is known for their robust privacy practices, which are all compliant with the required ethical laws and privacy legislation, to help them integrate the AI tool.  AI in client diagnostics ‘As part of using Jane's AI Scribe, therapy notes are included, but not diagnostic suggestions. As in, diagnostic suggestions are not coming from any AI-powered tool. Diagnostic suggestions are coming from a human, providing care to another human.' - Catharine Martin  Even though Jane App makes use of AI in some of their service offerings, they are critical of making sure that it is being used ethically and appropriately, and only for admin-related tasks.  The care suggestions and client diagnostics will still only come from you, the client's therapist, based on your sessions together. It is all up to you With your Jane App subscription, when it comes to AI, it is all up to you. You don't have to make sure of it, even though it is being offered to you.  You can easily opt in or out of using it within your Jane App subscription, hassle-free.  Also, consider the risk of any tool that you use when you are weighing up whether to use it or not.  Jane's appearance in The Globe and Mail Jane App made great headlines in one of The Globe and Mail's articles for reaching a $1.8-billion valuation.  Jane App is looking to adopt AI on a grand scale by continuing to explore its benefits ethically to help more helpers.  Connect with me: Instagram Website  Resources mentioned and useful links: Ep 169: Rachel Brennan: Keeping Connection in an Online Group Practice | EP 169  Learn more about the tools and deals that I love and use for my Canadian private practice Sign up for my free e-course on How to Start an Online Canadian Private Practice Jane App (use code FEARLESS for one month free) Get some help and freebies on your website with WordPress!  Learn more about Catharine on her LinkedIn profile Rate, review, and subscribe to this podcast on Apple Podcasts, Spotify, Amazon, and TuneIn

Le virus du papillome humain: Anne-Marie Ménard raconte son histoire-choc et invite à agir. Entrevue avec Anne-Marie Ménard, professionnelle en sexologie et autrice. Florence Lamoureux, journaliste à QUB. Regardez aussi cette discussion en vidéo via https://www.qub.ca/videos ou en vous abonnant à QUB télé : https://www.tvaplus.ca/qub ou sur la chaîne YouTube QUB https://www.youtube.com/@qub_radioPour de l'information concernant l'utilisation de vos données personnelles - https://omnystudio.com/policies/listener/fr

Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at  https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q 

Victoria Peterson and Dr. Bruce Baird reveal how diagnostic drift quietly erodes patient trust, team confidence, and long-term practice value. Learn how Clinical Calibration protects your philosophy of care and scales it across your team.

In today's episode, supported by Thermo Fisher Scientific, we had the pleasure of speaking with Apar Kishor Ganti, MD; and Allison Cushman-Vokoun, MD, PhD, FCAP, about the FDA approval of the Oncomine DX Express Test for use as a companion diagnostic for sunvozertinib (Zegfrovy) in EGFR exon 20 insertion mutation–positive non–small cell lung cancer and for use in tumor profiling. Dr Ganti is a professor in the University of Nebraska Medical Center (UNMC) Division of Oncology & Hematology, the Dr. and Mrs. D. Leon UMNC Research Fund Chair in Internal Medicine, and the associate director for Clinical Research at the Fred & Pamela Buffett Cancer Center in Omaha. Dr Cushman is the Henry F. Krous Professor of Pathology, a professor in the UNMC Department of Pathology, Microbiology and Immunology, director of the Division of Diagnostic Molecular Pathology and Human Genetics, medical director of the Molecular Diagnostics and Personalized Medicine Laboratory at Nebraska Medicine, director of the Molecular Genetic Pathology Fellowship Program, and associate director of the UMNC MD-PhD Scholars Program.  In our exclusive interview, Drs Ganti and Cushman discussed the significance of the launch of the Oncomine DX Express Test, the benefits and limitations of rapid next-generation sequencing, and features that set Oncomine DX apart from other available tests. 

Full article: Artificial Intelligence for Low-Dose CT Lung Cancer Screening: Comparison of Utilization Scenarios Shailin Thomas, MD, PhD, discusses the AJR article by Lee et al. comparing four utilization scenarios for the application of artificial intelligence to CT lung cancer screening.

As part of the 2025 Developmental Disabilities Conference, Dr. Eric London talks about understanding autism. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 40618]

As part of the 2025 Developmental Disabilities Conference, Dr. Eric London talks about understanding autism. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 40618]

As part of the 2025 Developmental Disabilities Conference, Dr. Eric London talks about understanding autism. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 40618]

Dr. David Spiegel is an author, psychiatrist and professor at Stanford University, and one of the world's leading experts into the clinical applications of hypnosis. He has published thirteen books, over 400 scientific articles, and 170 chapters on hypnosis, stress physiology, trauma, and psychotherapy. He is also the creator of REVERI, an innovative guided self hypnosis app which has been clinically proven to reduce stress, improve sleep, and enhance focus. In this lively and wide ranging conversation, we explore: — The exciting new science of clinical hypnosis and how it can be applied in the treatment of addiction and trauma — The importance of focusing on valued directions in clinical work and being a kind parent to yourself — Dr Spiegel's experiences working with Irvin Yalom and what he learned from him — The neural mechanisms that explain why clinical hypnosis works, including dissociation, cognitive flexibility, and absorption — The extent to which we can view hypnosis as a form of “internal exposure therapy”. And more. I used Dr Spiegel's REVERI app to help with sleep earlier this week and found myself out like a light within a few minutes, so I'd highly recommend giving it a try. You can learn more at https://www.reveri.com. --- Dr. David Spiegel is Willson Professor and Associate Chair of Psychiatry & Behavioral Sciences, Director of the Center on Stress and Health, and Medical Director of the Center for Integrative Medicine at Stanford University School of Medicine, where he has been a member of the academic faculty since 1975, and was Chair of the Stanford University Faculty Senate from 2010-2011. He has published thirteen books, over 400 scientific journal articles, and 170 chapters on hypnosis, psychosocial oncology, stress physiology, trauma, and psychotherapy. His research has been supported by the National Institute of Mental Health, the National Cancer Institute, the National Institute on Aging, the National Center for Complementary and Integrative Health, the John D. and Catherine T. MacArthur Foundation, the Fetzer Institute, the Dana Foundation for Brain Sciences, and the Nathan S. Cummings Foundation. He was a member of the work groups on the stressor and trauma-related disorders for the DSM-IV and DSM-5 editions of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders. He is Past President of the American College of Psychiatrists and the Society for Clinical and Experimental Hypnosis, and is a Member of the National Academy of Medicine. In 2018, Dr Spiegel was invited to speak on hypnosis at the World Economic Forum in Davos in 2018. --- 3 Books Dr Spiegel Recommends Every Therapist Should Read: — Dopamine Nation — Dr Anna Lembke - https://amzn.to/3O6NdKe — Trance and Treatment: Clinical Uses of Hypnosis 2nd Edition — Herbert Spiegel and David Spiegel - https://www.appi.org/Products/Psychotherapy/Trance-and-Treatment-Second-Edition — How to Change Your Mind — Michael Pollan - https://amzn.to/3OysDUw

Good morning everyone! Brett Wezel and Kevin Compass are back from their exhausting week full of disasters and fires!

Good morning everyone! Brett Wezel and Kevin Compass are back from their exhausting week full of disasters and fires!

In this episode of the PFC Podcast, Dennis and Ethan discuss the complexities of managing chest trauma in pre-hospital settings, focusing on the controversial topic of finger thoracostomy versus needle decompression. They explore the challenges of existing protocols, the importance of training and diagnostics, and the need for better data collection to improve outcomes in trauma care. The conversation emphasizes the significance of context in decision-making and the balance between equipment and training in emergency medical situations.Listen to this podcast AD-Free with premium membership on Spotify or Apple Podcast.TakeawaysThe conversation around chest trauma protocols is ongoing and complex.Finger thoracostomy is not universally applicable; context matters.Training and assessment are crucial in pre-hospital care.Infection risks must be considered with invasive procedures.Data collection in trauma care is often inadequate.Diagnostic techniques like ultrasound can improve decision-making.The effectiveness of procedures can vary based on patient condition.Equipment should complement, not replace, proper training.Understanding the nuances of trauma can lead to better outcomes.Protocols should be adaptable to different scenarios and providers.Chapters00:00 Introduction and Controversial Post02:04 Understanding Chest Trauma Protocols04:59 Exploring the IDF Trauma Registry Study09:54 Infection Risks and Protocol Considerations12:34 Training and Assessment in Pre-Hospital Care15:06 Diagnostic Techniques and Their Importance19:36 Evaluating the Effectiveness of Procedures23:29 The Role of Equipment vs. Training29:22 Data Collection for Better Outcomes35:29 Conclusion and Future ConsiderationsThank you to Delta Development Team for in part, sponsoring this podcast.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠deltadevteam.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠For more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠⁠⁠

Dr. Hugo Morales interviews Drs. Malco Rossi and Lucas Alessandro about their work on an AI-powered virtual assistant designed to aid in the diagnosis of chronic ataxias. They discuss how the assistant performed when put to the test, evaluating its diagnostic accuracy head-to-head against movement disorder experts. Journal CME is available until May 21, 2026 Read the article.

In this compelling episode, I sit down with integrative medicine pioneer Dr. Jeffrey Dach, MD, to explore his holistic, science-backed approach to fighting cancer. Drawing from his powerful book The Cancer Toolkit, Dr. Dach explains the core mechanisms behind cancer development and progression, and the multifaceted toolkit he uses to address it, from off-label pharmaceuticals and checkpoint inhibitors, to nutritional protocols, repurposed drugs, and targeted supplements. We also break down the three key cellular pathways that go awry in cancer, how to support the body's natural defenses, and why addressing the root cause—not just the tumor—is essential for long-term remission and recovery.  Topics We Cover: Dr. Dach's integrative and functional approach to cancer treatment Key drivers of cancer: inflammation, angiogenesis, metabolic dysfunction The most promising off-label drugs (e.g., metformin, mebendazole, statins) Why the Warburg effect matters—and how to target it Supplements with strong anti-cancer evidence Checkpoint inhibitors and immune activation Building a multi-modal protocol for better outcomes Patient empowerment and the future of cancer care  COMING SOON: Don't miss Part 2 of this interview, where we dive into Dr. Dach's newest book Bioidentical Hormones 101, and his trailblazing protocols for restoring hormonal health safely and naturally. Whether you're a practitioner, patient, or someone interested in cancer prevention, this episode delivers a deep dive into truly transformative insights. Connect with Dr Jeffrey: Website: Jeffreydachmd.com The Cancer Toolkit: Jeffreydachmd.com/books BIO: Special Guest - Dr. Jeffrey Dach Jeffrey Dach (pronounced DASH) was originally board certified in Diagnostic and Interventional Radiology and worked in the hospital setting for 25 years. After eye trouble, Dr. Dach retired from radiology and started a clinic specializing in bioidentical hormones and natural thyroid and continued this for the last 24 years. He is the author of Bioidentical Hormones 101, Natural Thyroid Toolkit, Heart Book and Cracking Cancer Toolkit.

Secretary of Health and Human Services Robert F. Kennedy, Jr. has spent years spreading doubt about the safety of vaccines and linking them to autism. Dozens of studies have debunked the theory, but it has nevertheless persisted for years. Part of the reason why may be that autism diagnoses have soared over the last few decades.Dr. Allen Frances is psychiatrist who led the task force that created the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders, which expanded the definition of Autism. Frances says that expanded definition played a role in the increase.Rates of autism have exploded in recent decades. Could the clinical definition of autism itself be partly to blame? For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org. Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Researchers at TU Dublin have secured over €650K to develop innovative cancer diagnostic technology under the prestigious Taighde Éireann - Research Ireland Pathway Programme. The award is part of a national €23 million investment announced today by Minister for Further and Higher Education, Research, Innovation and Science, James Lawless TD, aimed at empowering Ireland's emerging research leaders. "This investment, through Research Ireland's Pathway programme, will support emerging researchers in their journey from postdoctoral work towards establishing themselves as independent investigators. The projects receiving funding span a broad range of disciplines, ensuring a broad impact on scientific discovery and societal progress. By aligning with Ireland's national research priorities, these projects will help drive advancements in key sectors such as healthcare, environmental sustainability, history and education," stated Minister Lawless The research, led by Dr Anand V.R., a postdoctoral research fellow at TU Dublin's Photonics Research Centre (PRC), will combine two advanced light-based technologies - whispering gallery mode (WGM) sensing and surface-enhanced Raman scattering (SERS) - to build a powerful new tool for detecting cancer. This new system won't need chemical labels and will be highly sensitive, making it possible to quickly and accurately detect important cancer signals in the body, even in very small amounts. Based at TU Dublin's Photonics Research Centre, the project will benefit from the Centre's state-of-the-art facilities, including 90m of specialised lab space and a multidisciplinary research environment. The project will also engage a PhD student under the co-supervision of PRC Director Prof. Yuliya Semenova. Further collaboration will come from TU Dublin's Nanolab Research Centre (NRC), led by Dr Furong Tian, whose expertise in nanomaterials and nanoparticle modification will support the development of the sensor's biomedical capabilities. A key outcome of the project will be the creation of a proof-of-concept prototype for a rapid, non-invasive diagnostic tool that can detect minute quantities of breast cancer biomarkers in blood samples, offering promise for earlier detection and improved patient outcomes. "I am honoured to receive this support through the Taighde Éireann - Research Ireland Pathway Programme. This funding will enable us to develop a next-generation biosensing platform that merges the unique advantages of whispering gallery mode resonant sensing and surface-enhanced Raman scattering," said Dr Anand V.R. "Our goal is to dramatically improve the speed, sensitivity, and accuracy of breast cancer detection. This project is a testament to the collaborative research environment fostered at the Photonics Research Centre and Nanolab Research Centre, and I look forward to translating our scientific innovation into real-world clinical impact." Commenting on the awards, Celine Fitzgerald, Interim CEO, Research Ireland, said "Our Pathway programme equips promising researchers with the resources needed to reach the next level and help drive impactful discoveries. These projects will contribute valuable insights into pressing global and national issues, including public health policy, digital well-being, technological advancements, healthcare and more." The Taighde Éireann - Research Ireland Pathway Programme is co-funded by the Environmental Protection Agency (EPA), the Sustainable Energy Authority of Ireland (SEAI), and Met Éireann, contributing a total of €1.7 million to support projects with cross-sectoral relevance in sustainability, environment, and climate. For more information, please visit www.tudublin.ie/PRC More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-te...

In today's episode, I dive into a critical topic that NP school doesn't fully prepare you for - diagnostic errors in clinical practice. Unlike exams where wrong answers only affect your grade, real-world diagnostic mistakes can impact patient outcomes.   Together with my returning guest Courtney, we explore the different types of diagnostic errors and practical strategies to prevent them. Whether it's maintaining an open mind or advocating for your patient, we provide actionable steps for both new and experienced NPs.   Get full show notes, transcript, and more information here: https://blog.npreviews.com/prevent-diagnostic-errors-np-practice-essential-strategies/

Ceci est un extrait de l'épisode 220 avec Pr Nader Perroud, psychiatre. Voici le descriptif :Il y a bientôt un an, j'ai été diagnostiquée avec un TDAH qui est un trouble du déficit de l'attention avec ou sans hyperactivité et impulsivité.C'est une découverte qui a littéralement changé ma vie. Ça a été le début d'une longue recherche d'informations pour comprendre ce trouble, et c'est à ce moment-là que je suis tombée sur un professeur suisse spécialisé sur le TDAH et les femmes.Révélation.Nader Perroud est psychiatre, chercheur spécialisé dans ce trouble.Pourquoi est-ce que cet épisode est important? Parce que 5% de la population mondiale est touchée par cette atypie, ce qui représente en France pas moins de 3 400 000 personnes. Vous connaissez donc forcément quelqu'un qui souffre de ce problème. Et nous les femmes, sommes la catégorie la moins diagnostiquée.Dans cet épisode vous comprendrez comment se manifeste le TDAH, le lien avec nos hormones, la difficulté extrêmement présente d'être parent avec ce trouble, l'hérédité et bien plus encore.Si vous découvrez ce trouble ou si vous avez déjà des symptômes de ce trouble, le TDAH, alors cet épisode est fait pour vous.Si jamais ce n'est pas le cas mais vous vous posez plein de questions, alors cet épisode est fait pour vous.Si vous pensez avoir un ou une proche qui est atteint de ce trouble, alors cet épisode est fait pour vous. Si vous inquiétez simplement pour peut-être vous ou votre enfant, alors cet épisode est fait pour vous.Vraiment, vous allez découvrir pendant un peu plus d'une heure vingt ce monde incroyable du TDAH, de ses super pouvoirs, mais aussi des difficultés qu'il engendre dans la sphère familiale et la sphère professionnelle.

Send us a textEpisódio 57 – Journal Club 37 | Podcast A IncubadoraBem-vindo ao episódio 57 do Podcast A Incubadora, o seu encontro quinzenal com a ciência por trás da prática em Neonatologia - sempre em português e com foco em tornar a informação acessível a profissionais da saúde. Neste episódio do Journal Club, discutimos quatro artigos recentes que trazem reflexões importantes para a prática clínica em neonatologia:1) The effect of maternal position on cerebral oxygenation in premature infants during Kangaroo care (Journal of Perinatology, 2025) https://www.nature.com/articles/s41372-025-02287-02) Diagnostic accuracy of an over‑the‑counter infant pulse oximeter for cardiorespiratory events (ADC – Fetal and Neonatal, 2025) https://pubmed.ncbi.nlm.nih.gov/40355254/3) Intraventricular Hemorrhage and Survival, Multimorbidity, and Neurodevelopment (JAMA Network Open, 2025) https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2828692#google_vignette4) Use of Initial Endotracheal Versus Intravenous Epinephrine During Neonatal CPR in the Delivery Room (The Journal of Pediatrics, 2024) https://www.jpeds.com/article/S0022-3476(24)00161-6/abstractNosso objetivo é tornar a ciência neonatal mais acessível para quem fala português. Dê o play e atualize-se com a gente!

In this deeply moving episode, midwife and mother Ria shares her journey through motherhood with her daughter Olive, who has a rare genetic condition. Ria's story is one of resilience, advocacy and the profound love that comes with parenting a child with additional needs. If you’re preparing your nursery or planning for a new arrival, here’s a little heads-up you won’t want to miss. iL Tutto’s End of Financial Year Sale starts Monday 17th June and runs through to 11:59pm on 1st July – and it’s their biggest one yet. You’ll find up to 50% off their most-loved pieces – like the Felix Glider & Ottoman, the Como Cot Set, and the beautiful Lulu Vanilla Bouclé Chair. There’s also 30% off the Leo Electric Recliner and Glider, 20% off the sleek Maya Chair from their new Trend Collection, plus savings on Grow Kindly natural fibre sleepwear, Boba Baby Carriers, and Snuggle Me Organic Feeding Pillows. And just for Australian Birth Stories listeners, you’ll get an extra 5% off everything – even sale items – with the code ABS5 at checkout. Shop the sale from June 17th at iltutto.com.au and don’t forget to use code ABS5 at checkout.See omnystudio.com/listener for privacy information.

Dena Marrinucci, PhD, co-founder and COO of Truvian Health, joins the show to discuss her mission to transform blood diagnostics through a point-of-care device that delivers rapid, actionable results. She shares the origin story of founding Truvian in 2015—coincidentally just weeks before the Theranos exposé—and reflects on navigating industry skepticism in the post-Theranos landscape. Marrinucci also outlines the company's FDA submission process, the importance of empowering immediate patient-provider decision-making, and what the initial panel of 30+ lab tests offers for routine care, among so much more. Read the article on the Truvian Health blood test. https://www.newsweek.com/truvian-lab-company-blood-test-device-theranos-health-care-1997422 Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

The James Cancer Diagnostic Center has quickly become a valuable resource for the Central Ohio community and beyond. “Since we opened [in June 2020] we've had about 7,000 total visits … and about 40 percent have been diagnosed with some type of cancer,” said Tina Sowers, the Center's administrator. In this episode we are joined by Raquel Reinbolt, MD, medical director of the Center, Sowers, and Rupa Ghosh-Berkebile and Victoria Krogg, the Center's two advanced practice providers. The Center opened in the midst of the COVID epidemic. “The goal was to reach more patients and open a new front door to the James,” said Reinbolt, MD. She added people without a primary care physician can “self-refer to us and we can accommodate telemedicine visits. This leads to earlier diagnoses and better outcomes and quality of life. That's why we're such strong advocates for screenings and for not ignoring symptoms.” The Center is located on the 5th floor of the James Cancer Hospital on The Ohio State University campus. Suspecting you might have cancer, and then an actual diagnosis, can lead to heightened levels of anxiety. Ghosh-Berkebile and Krogg excel at helping patients understand their cancer diagnosis and to reduce some of their fears. “We help the patients understand what's happening to them and that we care about them,” Ghosh-Berkebile said.Krogg uses a whiteboard to describe complicated cancer and medical procedures. “It really helps, especially for patients who aren't familiar with medical terms, which is most patients. This job is rewarding because we help patients during a vulnerable time in their lives.” “And we let them know there is hope and we will get you to the right people at the James,” Ghosh-Berkebile added. The James Cancer Diagnostic Center is one of the first in the country, and other major cancer centers have taken notice. “Several of these cancer centers have reached out to us,” Sowers said. “They want to know how we're doing it and they want to learn from us.”

Bible StudyDon't just take our word for it . . . take His! We would encourage you to spend time examining the following Scriptures that shaped this sermon: .Sermon NotesI. The Fall and the Corruption of Work (Genesis 3)Sin enters through Adam and Eve's disobedience.Consequences: shame, hiding from God, broken partnership.Work is cursed:Pain in childbirth and relational struggle.Toil and frustration in labor (thorns, thistles, broken systems).Humanity tried to do life apart from God — the result is broken work.II. Three Pitfalls That Distort Work1. Individualism – Caring Too Much About Ourselves in WorkLuke 12: The rich fool stores wealth and speaks only to himself.God is absent from his plans and gratitude.Diagnostic questions:Is God your reference point?Do you use work to serve others?2. Idleness – Caring Too Little About the Work Itself2 Thessalonians 3: warning against laziness and not working.Broader definition of work: includes unpaid, volunteer, home-based.Matthew 25: Parable of the talents — don't bury your gifts.Idleness can stem from fear, not just laziness.3. Idolatry – Caring Too Much About WorkWork becomes identity or self-worth.Examples: over-identifying with parenting, business success, or ministry.Signs of idolatry:Can't stop working.Refusal to rest or Sabbath.Reminder of 6+1 rhythm of work and rest from creation.III. The Way Forward: The Cross and the SpiritThe Cross: Where we bring our sin and receive forgiveness.The Spirit: Empowerment for change and restored partnership with God.Through the Spirit, we can:Reject the lies of individualism, idleness, and idolatry.Embrace a God-centered, Spirit-empowered vision for work.Sermon ApplicationDiscussion Questions:What is one way you experience the distortion of work on a regular basis?To which of the pitfalls of work are you most susceptible?If you don't like your job, can you still honor God in it? How?If someone's work is raising kids, what might sabbath look like?Additional ResourcesThe Gospel at Work by Sebastian Traeger and Greg GilbertQuestions?Do you have a question about today's sermon? Email Randy Forrester ().

In this insightful discussion, Shelley Howard interviews Sean Ivester, founder of Pivot Tutors, about the evolving landscape of college entrance testing and effective test preparation strategies. Sean explains that test prep timing depends largely on the student's academic standing and course progression. He advises parents to avoid overlapping SAT/ACT prep with heavy academic periods like finals or AP exams to protect students' GPA, which remains crucial. The conversation highlights that successful test prep is not about cramming but a focused, diagnostic approach to target and strengthen weaknesses. Sean emphasizes the importance of a diagnostic test as the first step for understanding a student's readiness. He distinguishes the SAT and ACT, outlining their structure, differences, and upcoming changes—for example, the ACT's shortening and optional science section—helping families choose the right test. Sean also addresses the common challenge faced by high-performing students who still struggle initially on standardized tests, clarifying that knowing the material is different from “beating the test,” which requires specific strategies and fresh familiarity with foundational concepts. The conversation covers the pros and cons of various prep methods like apps, AI tools, and tutors, underscoring the critical role of accountability, motivation, and personalized instruction. Sean describes Pivot Tutors' unique approach of pairing students with specialized math and English tutors who are vetted, trained, and seasoned professionals, ensuring high-quality instruction catering to students' needs. The dialogue concludes with practical advice for parents: start early, use diagnostic testing to guide prep plans, and understand that sustained, focused prep yields the best outcomes. Sean stresses that test prep skills are transferable and beneficial well beyond college admission, supporting future academic and professional testing challenges.Highlights• Timing for test prep depends on student's course level and academic load—avoid overlap with finals/AP exams• Diagnostic tests are essential first steps to identify strengths, weaknesses, and guide prep focus• Effective prep targets weak areas instead of broadly reviewing all content to maximize score improvements• SAT is shorter and more complex reasoning-based; ACT is longer with broader math content and a fast pace, soon to be shorter and less time-pressured• High-achieving students often initially underperform on tests due to different test-taking skills needed• Personalized tutoring with specialized math and English tutors enhances accountability, motivation, and progress• Starting test prep early (end of sophomore year or early junior year) allows more flexibility and reduces panicKey Insights• Diagnostic Testing as a Starting Point: Sean underscores that a comprehensive diagnostic test reveals a student's starting point, exposing specific skill gaps and careless errors. This transforms test prep from a guessing game to a data-driven, strategic process, helping families decide when to start prep and which areas demand focus. Without this analysis, students risk inefficient study habits, wasting time and effort on content they already know or missing critical weak spots.• Timing and Academic Intensity Matter: Junior year is typically the most demanding academically, so scheduling test prep during summer or early fall yields better focus and outcomes. Families should avoid final seasons or AP exam periods for test prep to prevent academic overload, preserving GPA and mitigating burnout. This tailored timing recognizes student stress patterns and optimizes study efficiency.• Focused Practice Over Broad Content Review: The most effective way to improve standardized test scores is targeted practice on weak areas identified by diagnostic testing. Merely continuing to practice whole tests leads to plateauing scores. Instead, the cycle of focused drills, review, and retesting enables students to solidify understanding and see measurable gains. This approach shifts prep from volume-based to precision-based, enhancing motivation and confidence.• Choosing Between SAT and ACT Requires Individual Evaluation: No test suits everyone; SAT and ACT differ in length, pacing, question style, and focus areas. For example, the SAT involves complex reasoning and is slightly shorter, while the ACT covers broader math content with faster pacing. Upcoming changes, like the ACT's optional science section and shorter length, further complicate the choice. Therefore, Sean advises students to take practice tests for both and compare scores—avoiding decisions based on hearsay or anecdotal evidence.• Test Scores Reflect Test-Taking Skills, Not Just Intelligence: Top academic performers can score below expectations initially because standardized tests require specialized strategies distinct from classroom learning. Some fundamental concepts tested might have been learned long ago and need refreshing. Effective test prep rebuilds these foundations and teaches "how to beat the test," focusing on timing, question interpretation, and pacing rather than pure intellect.• Accountability and Personalized Instruction are Game-Changers: The challenges of self-motivation and competing academic priorities mean many students struggle to commit regular prep time independently. Professional tutors provide structure, coaching, and encouragement. Pivot Tutors' model of assigning two specialized tutors—one for math, one for English—ensures that students get subject-specific expertise and tailored lesson plans. Rigorous vetting and continuous training of tutors guarantee high teaching quality and effective communication.• Early Planning Eases Stress and Opens Doors: Starting the test prep planning at the end of sophomore year provides ample time for assessment, practice, and adjustment. It avoids the “frantic” last-minute rush many rising seniors experience. Early prep offers the flexibility to try multiple test dates and strategies, increasing chances of reaching target scores and keeping options open for college admissions and scholarships.• Test Prep Skills Provide Long-Term Benefits: Beyond college admissions, mastering standardized testing techniques develops critical thinking, problem solving, and test endurance skills essential for future academic tests like the LSAT, MCAT, or MBA entrance exams. Early investment in effective test prep equips students with lifelong skills to navigate competitive exams and professional challenges.• Navigating Prep Tools: Apps and AI vs. Human Tutors: While online tools and AI like ChatGPT offer convenience, Sean highlights their limitations due to lack of accountability, motivation, and nuanced, personalized feedback. Human tutors facilitate adaptive learning, real-time interaction, and emotional support, which are often crucial to overcome motivational roadblocks and plateaus. Families must weigh student personality and discipline when choosing prep methods.• Tutor Selection and Training Reflect Company Quality: Pivot Tutors' rigorous hiring includes academic degree requirements, high proficiency test scores, and in-person mock tutoring evaluations. This multi-tiered vetting ensures tutors are not only knowledgeable but excellent communicators who can simplify complex concepts. Shadowing experienced tutors and ongoing training help maintain consistent, student-centered pedagogy that respects students' time and academic pressure.• Iterative Process of Testing and Retesting: Sean emphasizes that improvement comes from cycles of testing, reflection, and focused practice—not one-off studying. Continuous assessment allows students and tutors to track progress, refine strategies, and build confidence. This iterative process contrasts sharply with less effective “all content at once” study methods.• Parental Support is Crucial but Must Balance Pressure: Parents play a vital role in encouraging the right preparation habits while avoiding overwhelming their teens. Educating parents about strategic prep planning, early diagnostic testing, and the reality of test demands empowers them to guide their children calmly and effectively, minimizing stress.This interview offers a comprehensive roadmap for families navigating the changing test prep landscape, emphasizing strategic timing, targeted study, professional guidance, and early planning for long-term benefits. and effective communication.Early Planning Eases Stress and Opens Doors: Starting the test prep planning at the end of sophomore year provides ample time for assessment, practice, and adjustment. It avoids the “frantic” last-minute rush many rising seniors experience. Early prep offers the flexibility to try multiple test dates and strategies, increasing chances of reaching target scores and keeping options open for college admissions and scholarships.Test Prep Skills Provide Long-Term Benefits: Beyond college admissions, mastering standardized testing techniques develops critical thinking, problem solving, and test endurance skills essential for future academic tests like the LSAT, MCAT, or MBA entrance exams. Early investment in effective test prep equips students with lifelong skills to navigate competitive exams and professional challenges.Navigating Prep Tools: Apps and AI vs. Human Tutors: While online tools and AI like ChatGPT offer convenience, Sean highlights their limitations due to lack of accountability, motivation, and nuanced, personalized feedback. Human tutors facilitate adaptive learning, real-time interaction, and emotional support, which are often crucial to overcome motivational roadblocks and plateaus. Families must weigh student personality and discipline when choosing prep methods.Tutor Selection and Training Reflect Company Quality: Pivot Tutors' rigorous hiring includes academic degree requirements, high proficiency test scores, and in-person mock tutoring evaluations. This multi-tiered vetting ensures tutors are not only knowledgeable but excellent communicators who can simplify complex concepts. Shadowing experienced tutors and ongoing training help maintain consistent, student-centered pedagogy that respects students' time and academic pressure.Iterative Process of Testing and Retesting: Sean emphasizes that improvement comes from cycles of testing, reflection, and focused practice—not one-off studying. Continuous assessment allows students and tutors to track progress, refine strategies, and build confidence. This iterative process contrasts sharply with less effective “all content at once” study methods.Parental Support is Crucial but Must Balance Pressure: Parents play a vital role in encouraging the right preparation habits while avoiding overwhelming their teens. Educating parents about strategic prep planning, early diagnostic testing, and the reality of test demands empowers them to guide their children calmly and effectively, minimizing stress.This interview offers a comprehensive roadmap for families navigating the changing test prep landscape, emphasizing strategic timing, targeted study, professional guidance, and early planning for long-term benefits.Connect with Shellee Howard:Website: www.collegereadyplan.com/YouTube: www.youtube.com/channel/UCr_WodPHDfSWEbiPdsRDbyQInstagram: https://www.instagram.com/collegereadyplan/LinkedIn: https://www.linkedin.com/company/college-ready/Email: shellee@collegereadyplan.comConnect with Sean IvesterWebsite: https://www.pivottutors.comInstagram: @pivottutorsTikTok: @testpreptipsLinkedIn: https://www.linkedin.com/in/seanivester/Email: sean@pivottutors.com

In this insightful and comprehensive discussion, Shelley Howard hosts Jackie Pollina, founder of J&J Test Prep and No BS SAT Prep, to explore the critical role of test preparation in high school and college admissions. Jackie shares her entrepreneurial journey from a stressed high school test-taker to a passionate business owner who creates modern, digestible test prep approaches. They emphasize the ongoing importance of standardized testing, even in a test-optional world, highlighting how strong scores enhance admission chances and secure substantial scholarships. The conversation debunks common myths around the SAT and ACT, recommending personalized diagnostic testing to determine the best fit for each student. They also provide detailed guidance on the various test prep formats—private tutoring, intensive classes, and crash courses—tailored to different goals and preparation timelines, underscoring the need for strategic, multi-test preparation over time. Additionally, the dialogue touches on AP exam support, summer prep advantages, and the importance of proactive parental involvement. Real-life experiences reinforce the long-term impact of solid test strategies, demonstrating how early preparation benefits students well beyond admission, even into professional exams like the MCAT. Finally, they encourage parents to engage actively with test prep resources to maximize scholarship opportunities and optimize college readiness.HighlightsJackie Pollina founded J&J Test Prep with a mission to make test preparation modern, relatable, and manageable.Test-optional admissions still favor students with strong standardized test scores for admission chances and merit scholarships.Diagnostic testing is essential to decide whether a student should take the SAT or ACT based on individual strengths and timing.Effective test prep requires at least eight weeks and ideally multiple test attempts for significant score improvement.Strategic test prep can dramatically increase scores, influencing college admission and scholarship opportunities.Summer is the optimal season for test prep due to fewer academic distractions and more available study time.Test preparation is a skill that supports future professional exams, making early preparation an investment beyond college admissions.Key InsightsTest Prep as a Long-Term Skill: Jackie and Shelley stress that testing is not a one-time hurdle but a lifelong skill essential for careers requiring professional exams like the LSAT, MCAT, or boards. This reframing helps parents and students view test prep as a beneficial investment rather than a temporary chore. Developing strategies early fosters confidence and competence for decades ahead, reinforcing the importance of embracing test prep rather than avoiding it.The Nuances of Test-Optional Policies: While many students celebrate test-optional admissions by skipping tests, data shows that students with strong scores tend to be admitted more often and awarded more merit-based aid. Colleges remain flexible but often encourage submissions. This “test-optional” not “test-irrelevant” distinction is vital for families to understand—relying solely on test-optional policies can be risky if future admissions cycles change policies unexpectedly.Customized Test Selection via Diagnostics: Deciding between the SAT and ACT cannot be done on surface-level preferences or perceived subject strengths. Diagnostic exams provide a data-driven approach to uncover a student's natural aptitude, timing skills, and question-type preferences. This personalized method ensures students invest effort in the test most aligned with their abilities, optimizing their potential outcomes and reducing unnecessary frustration.Time Investment is Key for Meaningful Score Gains: Test prep is not a quick fix. Significant improvements (e.g., 200+ points on the SAT) require sustained, individualized preparation often through private tutoring. More moderate improvements can be obtained in structured classes. Crash courses serve as last-minute boosters but cannot replace comprehensive prep. This underscores the importance of planning ahead, managing expectations, and resisting the “one-and-done” test mindset.Scholarships Depend Heavily on Scores: Test scores play a critical role beyond admission—they are often a primary factor in awarding merit scholarships, which can substantially reduce the financial burden of college. Shelley's real-world story of her son's 300-point SAT improvement illustrates how strategic prep can be a financial game-changer, converting a generic state school opportunity into elite college admission, with profound long-term benefits.Summer Offers a Strategic Advantage: Utilizing summer breaks for test prep takes advantage of reduced academic stress and increased availability to focus on study. This timing allows students to absorb material effectively, avoid burnout during the school year, and be prepared for fall test dates. Summer prep is a smart, balanced approach rather than forcing test prep during already demanding school months.Parental Support and Realistic Expectations Are Vital: Students often dread test prep; motivation can be low. Hence, parental involvement is crucial to facilitate scheduling, advocate for professional help such as test strategists, and nurture a growth-oriented mindset around testing. Being a proactive, informed parent translates into better prep options, well-timed testing, and ultimately superior outcomes for the student.ConclusionThe conversation between Shelley Howard and Jackie Pollina serves as a valuable resource for families navigating the complexities of college test preparation. It offers evidence-based guidance on choosing tests, appropriate timing, and tailored prep formats, while also underscoring the financial and long-term personal benefits of mastering test-taking skills. Parents are empowered to approach test prep proactively and strategically, ensuring their teens maximize college admission and scholarship opportunities, and set the stage for future academic resilience.Connect with Shellee Howard:Website: www.collegereadyplan.com/YouTube: www.youtube.com/channel/UCr_WodPHDfSWEbiPdsRDbyQInstagram: https://www.instagram.com/collegereadyplan/LinkedIn: https://www.linkedin.com/company/college-ready/Email: shellee@collegereadyplan.comConnect with Jacqueline PollinaWebsite: www.jjtestprep.com/Facebook: https://www.facebook.com/jackie.pollina.sat.prep/                   www.facebook.com/jjtestprepInstagram: @jjtestprepTikTok: @testpreptipsEmail: contact@jjtestprep.com

durée : 00:08:32 - La Question du jour - par : Marguerite Catton - Ce mardi, l'Assemblée nationale a adopté à l'unanimité un texte de loi, issu d'une commission mixte paritaire, visant à redéfinir les compétences de la profession d'infirmier. Grâce à cette loi, les infirmiers pourront mener des consultations, poser un diagnostic et prescrire certains soins. - réalisation : Félicie Faugère - invités : Nsuni Met Docteure en sciences de gestion, qualifiée en sciences infirmières, chercheuse associée au laboratoire Arènes

Jeudi 12 juin, François Sorel a reçu Julien Billot, président de Scale Ai, Pablo Piantanida, directeur de l'ILLS (International Laboratory on Learning Systems), professeur associé à l'ÉTS à Montréal, et Jérémie Voix, professeur titulaire à l'ÉTS à Montréal. Ils ont parlé de la tech canadienne qui fait une entrée en force à VivaTech, d'une intelligence artificielle qui sert à diagnostiquer le cancer du sein, et des prothèses auditives révolutionnaires, dans l'émission Tech & Co, la quotidienne, sur BFM Business. Retrouvez l'émission du lundi au jeudi et réécoutez la en podcast.

Maurice Gourdault-Montagne : Ex-Ambassadeur de France au Japon, Chine et Grande-Bretagne.

Today my guests are Dr Meriem Sefta, Chief Diagnostics Officer at Owkin, and Amanda Coble, Senior Director of Product at Proscia.  What we discuss with Amanda and Dr Sefta: The history of Owkin Founding vision and early challenges Deep learning in pathology Mission and Precision Oncology Digital pathology and AI integration Biomarker screening products like MSIntuit CRC Outcome prediction solutions like RLapseRisk BC Partnership with Proscia The future of pathology with AI Interoperability and collaboration Disclaimer: MSIntuit CRC, BRCAura BC, and RlapsRisk BC are under development and not for clinical use. They are not FDA cleared or approved in the USA. BRCAura BC and RlapsRisk BC are developed within the PortrAIt consortium, a french consortium financed by the government within the framework of France 2030 and by the European Union - Next Generation EU within the framework of the France Relance Plan. Owkin interoperability with Proscia's software is for Research Use Only. Not for use in diagnostic procedures. Links for this episode: The Path to PathA Pathologists' Assistant Shadowing Network Health Podcast Network  LabVine Learning Dress A Med scrubs Digital Pathology Club   Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients Owkin Proscia   People of Pathology Podcast: Twitter Instagram  

Are your patients just healthy, or are you underdiagnosing treatment? In this episode of Metric Mondays, Kirk Behrendt brings back Miranda Beeson, ACT's director of education, to break down diagnostic percentage, why your numbers are low, and ways to start impacting this metric today. To learn how to be proactive in diagnosing care, listen to Episode 897 of The Best Practices Show!Learn More About Miranda:Send Miranda an email: miranda@actdental.com Follow Miranda on ACT's Instagram: https://www.instagram.com/actdentalSend Courtney an email to learn more about ACT: courtney@actdental.com More Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 897: https://www.youtube.com/@actdental/videosRegister for ACT's To The Top Study Club (July 18th, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-18-2025-ttt-study-club-tickets-1205460116659Register for ACT's To The Top Study Club (July 25, 2025): https://www.eventbrite.com/e/climb-with-us-register-for-july-25-2025-ttt-study-club-tickets-1205497959849Main Takeaways:Establish a baseline for what you consider healthy.Talk to patients about the positive outcomes of treatment.Understand what low and high diagnostic percentages indicate.Leverage co-discovery and co-diagnosis. When patients see, they do.Utilize technology such as Pearl AI as a way to offer a second opinion.Snippets:0:00 Introduction.1:55 Diagnostic percentage, explained.3:25 Selling is...

In this episode, Bryan and Roman dive deep into the world of Variable Refrigerant Flow (VRF) systems, focusing on the persistent issue of compressor failures. VRF technology has evolved, and it has seen a major rise in the North American market since the early 2010s. Roman shares his passion for VRF, tracing its origins back to 1982 and explaining how it earned the nickname “chiller killer” by replacing traditional chiller systems in large facilities like hotels, churches, and schools. However, with this rapid adoption came a troubling reputation: VRF systems became notorious for frequent compressor failures, prompting some institutions to revert to older technologies. There are three primary causes of compressor failure in VRF systems: oil lubrication issues, liquid refrigerant return, and electrical failures. VRF compressors are shipped with excess oil to account for the system's extensive piping and multiple indoor units, but improper refrigerant charge—either overcharging or undercharging—can disrupt oil return and lead to gradual compressor death. They emphasize the importance of correct installation, accurate charge calculation, and diligent maintenance. Bryan adds that measuring discharge superheat is a key diagnostic tool: high discharge superheat with normal suction superheat signals poor lubrication and impending failure. The discussion then shifts to the dangers of liquid refrigerant returning to the compressor. Even small amounts can wash oil off the scroll plates, leading to metal-on-metal contact, galling, and eventual mechanical breakdown. Roman details the difference between high-pressure shell and low-pressure shell compressors, noting that VRF systems are more susceptible to operational flood back, which can cause elevated amp draws and catastrophic failure. They also highlight the role of contamination—such as copper shavings or sand from installation—which can damage expansion valves and lead to chronic flood back issues. Maintenance, including regular oil analysis and monitoring of expansion valve performance, is crucial for long-term reliability. Finally, the episode covers electrical failures, often the result of underlying mechanical issues rather than true electrical faults. The hosts advocate for using insulation resistance testing (megohmmeters) as a maintenance tool to track winding degradation over time. They stress that proper cleanup after a compressor failure is vital, recommending temporary filter dryers and oil analysis to mitigate contamination. The conversation closes with practical advice: always investigate the root cause of a compressor failure, communicate findings with clients, and prioritize best practices in installation and service to prevent repeat issues.  Topics Covered in This Episode: The history and rise of VRF technology in North America Why VRF systems earned the nickname “chiller killer” The three primary causes of VRF compressor failure: Oil lubrication issues (overcharge/undercharge, oil return) Liquid refrigerant return (flood back, expansion valve failures) Electrical failures (mechanical causes, insulation degradation) Diagnostic techniques: discharge superheat, suction superheat, amp draw analysis The impact of installation practices and system contamination Maintenance best practices: oil analysis, filter dryers, insulation resistance testing The importance of root cause analysis after compressor failures Resources for ongoing VRF education: VRF Tech Talk podcast, Facebook group, and Roman's YouTube channel   Have a question that you want us to answer on the podcast? Submit your questions at https://www.speakpipe.com/hvacschool. Purchase your tickets or learn more about the 6th Annual HVACR Training Symposium at https://hvacrschool.com/symposium. Subscribe to our podcast on your iPhone or Android. Subscribe to our YouTube channel. Check out our handy calculators here or on the HVAC School Mobile App for Apple and Android

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss global trends in diagnostic manufacturing and their implications for laboratory professionals. Topics include: Emerging innovations in mass spectrometry, next-generation sequencing, automation, and artificial intelligence. Fierce competition in the global manufacturing landscape as new companies enter the market. Geopolitical dynamics influencing where innovations are deployed. Why laboratory professionals need to drive innovation implementation to maximize benefits for clinicians and their patients.

In this urgent and deeply moving episode, Michelle sits down with Emma Cloney and Diana Dimmock—two powerful advocates from Lipedema Canada—to talk about the medical condition most clinicians have never even heard of, despite its potential to affect 1 in 9 women.Together, they dive into:What lipedema actually is—and how it differs from lymphedema and obesityWhy lipedema is painful, progressive, and devastating when left untreatedThe staggering lack of awareness in Canadian medical schools and healthcare systemsHow fatphobia, gender bias, and medical gaslighting keep patients in the darkThe emotional and financial toll of living with an unrecognized conditionPractical resources for patients and cliniciansWhat needs to change—and how we can all be part of that changeThis episode is more than just a discussion—it's a rallying cry for justice, compassion, and recognition.Whether you're a clinician, patient, or simply someone who cares about women's health, you don't want to miss this conversation.Resources Mentioned:Lipedema Canada – For patient info, clinician resources, advocacy tools & supportLipedema.org (US-based) – Diagnostic tools and educational materialsFollow @LipedemaCanada on social media for shareable awareness contentMore About Our Guests:Emma Cloney Emma Cloney is a Women's Health Nurse and the Vice President and co-founder of Lipedema Canada / Lipœdème Canada, the national nonprofit association for lipedema dedicated to raising awareness, improving access to care, and advancing research for people living with lipedema—a chronic and often misdiagnosed fat disorder that primarily affects women.Emma brings over ten years of clinical experience and a deeply personal connection to this work. Diagnosed with lipedema in 2021, she became the first Canadian to receive multiple mobility-preserving surgeries for the condition funded through provincial healthcare—after successfully advocating for policy change in Manitoba. Her experience highlighted the serious gaps in diagnosis, treatment, and public awareness across Canada.In response, Emma co-founded Lipedema Canada in 2023 alongside a group of passionate patients from across the country. Today, she leads the organization's clinical outreach and education efforts, working to empower patients and healthcare providers alike. Whether she's speaking to policymakers, clinicians, or fellow patients, Emma is committed to changing the narrative around lipedema and ensuring that no one faces this condition alone.Lipedema CanadaDiana Dimmock Diana Dimmock is the founder of Accessibility 4 Every Body Consulting, a size-inclusive consulting firm based in Sherwood Park, Alberta. As an advocate, educator, and speaker, Diana is passionate about promoting accessibility and inclusivity for people of all body sizes and abilities. Through her work, she challenges the marginalization of larger bodies and assists organizations in creating more welcoming, inclusive environments. Through her business, Diana offers valuable insights into the intersection of size, ability, and access, making her a powerful voice in the push for equity and inclusion.Recently diagnosed with lipo-lymphedema, Diana has identified this condition as a long-standing aspect of her health since adolescence. While struggling to seek appropriate medical care and experiencing discrimination based on her body size, Diana became dedicated to ensuring that all individuals receive equitable healthcare. She is deeply committed to self-advocacy and raising awareness with the public and with healthcare professionals about lipedema in Canada. Diana is dedicated to supporting efforts in advocating for improved diagnosis and management strategies for this condition with Lipedema Canada.https://linktr.ee/accessibility4everybodyFind Diana on LinkedIn here. 

Did you know that Obsessive-Compulsive Disorder (OCD) affects approximately 1 in 200 children, with symptoms often emerging between the ages of 7 and 12? As pediatricians, you're likely the first to encounter these patients, making early recognition and intervention critical for achieving optimal outcomes. In this episode, we'll provide you with the knowledge and tools needed to accurately diagnose and effectively manage OCD, laying the foundation for better long-term care. Dr. Theresa Fiagbe, a second-year Child Psychiatry Fellow, Dr. Dale Peeples, Associate Professor of Child Psychiatry, and Alisha Patel, Medical Student at the Medical College of Georgia, join forces to unpack the complexities of OCD in children and adolescents. Tune in as we: Explore key diagnostic criteria and the most effective screening tools for identifying OCD in pediatric patients Discuss evidence-based treatments such as Cognitive Behavioral Therapy (CBT) and SSRIs, and how to incorporate them into your practice Review common comorbid conditions, like anxiety and PANDAS, that can complicate diagnosis and treatment Examine the impact of OCD on school performance, social interactions, and family life Share practical guidance on managing long-term care to prevent relapse and ensure successful outcomes Whether you're encountering OCD symptoms in a patient for the first time or seeking to enhance your expertise, this episode will equip you with the essential tools to improve diagnosis and treatment. Special thanks to Dr. Yang for editing and Dr. Sarah Straka, and Dr. Baris Olten for peer reviewing this episode. CME Credit Available: Link Coming Soon! References: American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing. Berman, L., & Flessner, C. A. (2014). Pediatric obsessive-compulsive disorder: Diagnostic and treatment issues. Journal of the American Academy of Child and Adolescent Psychiatry, 53(2), 123-131. https://doi.org/10.1016/j.jaac.2013.10.003 Clark, C. A., & Scharf, R. (2020). Cognitive-behavioral therapy for obsessive-compulsive disorder in children and adolescents: Current trends and future directions. Journal of the American Academy of Child and Adolescent Psychiatry, 59(9), 971-979. https://doi.org/10.1016/j.jaac.2020.05.007 Fahrion, S., & Goodwin, G. M. (2019). Pharmacological treatment of pediatric obsessive-compulsive disorder: SSRIs, clomipramine, and beyond. Current Psychiatry Reports, 21(8), 58-66. https://doi.org/10.1007/s11920-019-1040-3 Franklin, M. E., & March, J. S. (2015). Treatment of obsessive-compulsive disorder in children and adolescents. Pediatric Clinics of North America, 62(3), 529-545. https://doi.org/10.1016/j.pcl.2015.02.004 March, J. S., & Mulle, K. (2017). OCD in children and adolescents: A review of treatments and practical guidance. The Psychiatric Clinics of North America, 40(2), 199-208. https://doi.org/10.1016/j.psc.2017.01.002 Murphy, T. K., & Pincus, D. B. (2019). Pediatric obsessive-compulsive disorder: Diagnosis, treatment, and future directions. Current Opinion in Pediatrics, 31(4), 517-524. https://doi.org/10.1097/MOP.0000000000000801 PANDA Study Group. (2017). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Journal of the American Academy of Child and Adolescent Psychiatry, 56(11), 933-940. https://doi.org/10.1016/j.jaac.2017.07.866 Peris, T. S., & Piacentini, J. (2021). Pediatric obsessive-compulsive disorder: Treatment strategies and challenges. Journal of Clinical Child and Adolescent Psychology, 50(1), 32-43. https://doi.org/10.1080/15374416.2020.1831504 Reaven, J. (2018). Screening for pediatric obsessive-compulsive disorder: Tools, guidelines, and challenges. Child and Adolescent Mental Health, 23(3), 133-139. https://doi.org/10.1111/camh.12267 Thienemann, M., & McGuire, L. (2019). Treating pediatric OCD with a focus on cognitive-behavioral therapy: Evidence and efficacy. Journal of Clinical Child and Adolescent Psychology, 48(4), 530-538. https://doi.org/10.1080/15374416.2019.1612851

In this episode of the Becker's Healthcare Podcast, Brian Zimmerman speaks with Dr. Mindy Nye, Vice President at Labcorp, about the evolving role of diagnostic laboratory science and how innovation is transforming patient care. Dr. Nye explores the meaning of “diagnostic innovation,” the technologies reshaping lab capabilities, and how these advancements are creating new value for health systems. Tune in for expert insights on why the clinical lab is becoming an increasingly strategic asset in modern healthcare.This episode is sponsored by labcorp.

Episode 192: ADHD Treatment.  Jordan Redden (MSIV) explains the treatment of ADHD. Dr. Bustamante adds input about pharmacologic and non-pharmacologic treatments. Dr. Arreaza shares the how stimulants were discovered as the treatment for ADHD. Written by Jordan Redden, MSIV, Ross University School of Medicine. Comments and edits by Isabelo Bustamante, MD, and Hector Arreaza, MD. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Introduction.ADHD is a chronic neurodevelopmental condition characterized by inattention, impulsivity, and/or hyperactivity. While it's often diagnosed in childhood, symptoms can persist well in adulthood. The treatment for ADHD is multifaceted. It often includes medication, behavioral therapy, environmental modifications, and sometimes educational interventions which are especially effective in younger patients. Ongoing evaluation is needed during treatment. Treatment needs adjustments over time.Starting with medications: Stimulants are the most well-studied and effective pharmacologic treatment for ADHD. These include methylphenidate-based medications such as Ritalin, Concerta, and Focalin, and amphetamine-based options, like Adderall, Vyvanse, and Dexedrine. Discovery of stimulants for ADHD> Dr. Charles Bradley discovered stimulants as the treatment for ADHD around 1937. ADHD did not have a name at that time, but it was known that some children had behavioral problems related to poor attention and inability to control their impulses, but they were still intelligent. Dr. Bradley was a psychiatrist who was working in the Bradley Hospital (Rhode Island), he was studying these children and, as part of his experiments, they developed severe headaches. He gave “Benzedrine” (a decongestant) to his pediatric patients to treat severe headaches, and he discovered that Benzedrine improved academic performance and interest in school and improved disruptive behavior in some children.How do stimulants work.Stimulants work primarily by increasing dopamine and norepinephrine levels in the brain, which helps improve focus, attention span, and impulse control. They typically show a rapid onset of action and can lead to noticeable improvements within the first few days of use. Dosing is individualized and should start low with gradual titration. Side effects can include reduced appetite, insomnia, headaches, increased heart rate, and emotional lability.Types of stimulants. Stimulants come as short acting and long acting. They can come as a tablet, liquid, patch, or orally disintegrating tablet. After the discovery of Benzedrine as a possible treatment for ADHD, more research was done over the years, and Ritalin became the first FDA-approved medication for ADHD (1955). The list of medications may seem overwhelming, but there are only two types of stimulants used to treat ADHD: methylphenidate and amphetamine. Long-acting stimulant medications are often preferred for their consistent symptom control and lower potential for misuse. Vyvanse (lis-dexa-mfetamine) is a widely used long-acting amphetamine-based option. As a prodrug, it remains inactive until metabolized in the body, which results in a smoother onset and offset of action and may reduce the risk of abuse. This extended duration of effect can help patients maintain focus and regulate impulses throughout the day without the peaks and crashes sometimes seen with shorter-acting formulations. Of note, Vyvanse is also approved for Binge Eating Disorder. Many of these medications are Schedule II controlled substances, so to prescribe them you need a DEA license. Other long-acting options include Concerta, an extended-release methylphenidate, as well as extended-release versions of Adderall and Focalin. These are especially helpful for school-aged children who benefit from once-daily dosing, and for adults who need sustained attention during work or academic activities. The choice between short- and long-acting stimulants depends on individual response, side effect tolerance, and daily routine.For patients who cannot tolerate stimulants, or for those with contraindications such as a history of substance misuse or certain cardiac conditions, non-stimulant medications are an alternative. One of the most used is atomoxetine, which inhibits the presynaptic norepinephrine transporter (NET). This leads to increased levels of norepinephrine (and to a lesser extent dopamine). Guanfacine or clonidine are alpha-2A adrenergic receptor agonists that lead to reduced sympathetic outflow and enhanced prefrontal cortical function, improving attention and impulse control. These alpha agonists are particularly useful in younger children with significant hyperactivity or sleep disturbances.Non-pharmacologic treatments.Behavioral therapy before age 6 is the first choice, after that, medications are more effective than BH only, and as adults again you use CBT.Medication is often just one part of a broader treatment plan. Behavioral therapy, especially in children, plays a critical role. Parent-training programs, positive reinforcement systems, and structured routines can significantly improve functioning. And for adolescents and adults, cognitive-behavioral therapy (CBT) is particularly helpful. CBT can address issues like procrastination, time management, emotional regulation, and self-esteem which are areas that medication doesn't always touch.Using medications for ADHD can be faced with resistance by parents, and even children. There is stigma and misconceptions about mental health, there may be concerns about side effects, fear of addiction, negative past experiences, and some parents prefer to treat ADHD the “natural” way without medications or only with supplements. All those concerns are valid. Starting a medication for ADHD is the first line of treatment in children who are 6 years and older, but it requires a shared decision with parents and patients. Cardiac side effects are possible with stimulants. EKG may be needed before starting stimulants, but it is not required. Get a personal and family cardiac history, including a solid ROS. Benefits include control of current condition and treating comorbid conditions.The presentation of ADHD changes as the person goes through different stages of life. For example, you may have severe hyperactivity in your school years, but that hyperactivity improves during adolescence and impulsivity worsens. It varies among sexes too. Women tend to present as inattentive, and men tend to be more hyperactive. ADHD is often underdiagnosed in adults, yet it can significantly impact job performance, relationships, and mental health. In adults, we often use long-acting stimulants to minimize the potential for misuse. And psychotherapy, particularly CBT or executive functioning coaching, can be life-changing when combined with pharmacologic treatment. There are several populations where treatment must be tailored carefully such as pregnant patients, individuals with co-occurring anxiety or depression, and those with a history of substance use. For example, atomoxetine may be preferred in patients with a history of substance misuse. And in children with coexisting oppositional defiant disorder, combined behavioral and pharmacologic therapy is usually more effective than either approach alone.Comorbid conditions.Depression and anxiety can be comorbid, and they can also mimic ADHD. Consult your DSM-5 to clarify what you are treating, ADHD vs depression/anxiety.Treatment goes beyond the clinic. For school-aged children, we often work closely with schools to implement 504 plans or Individualized Education Programs (IEPs) that provide classroom accommodations. Adults may also benefit from workplace strategies like structured schedules, noise-reducing headphones, or even coaching support. Ongoing monitoring is absolutely essential. We assess side effects of medication, adherence, and symptom control. ***In children, we also monitor growth and sleep patterns. We often use validated rating scales, like the Vanderbilt questionnaire for children 6–12 (collect answers from two settings) or Conners questionnaires (collect from clinician, parents and teachers), to track progress. And shared decision-making with patients and families is key throughout the treatment process.To summarize, ADHD is a chronic but manageable condition. Effective treatment usually involves a combination of medication and behavioral interventions, tailored to the individual's needs. And early diagnosis and treatment can significantly improve quality of life academically, socially, and emotionally.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed., text rev. (DSM-5-TR). Washington, DC: American Psychiatric Association; 2022. CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder). Understanding ADHD. Accessed May 2025. https://chadd.org National Institute for Health and Care Excellence (NICE). Attention Deficit Hyperactivity Disorder: Diagnosis and Management. NICE guideline [NG87]. Updated March 2018. Accessed May 2025. https://www.nice.org.uk/guidance/ng87 Pliszka SR; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921. doi:10.1097/chi.0b013e318054e724 Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):e20192528. doi:10.1542/peds.2019-2528 Texas Children's Hospital. ADHD Provider Toolkit. Baylor College of Medicine. Accessed May 2025. https://www.bcm.edu Wolraich ML, Hagan JF Jr, Allan C, et al. Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis. UpToDate. Published 2024. Accessed May 2025.https://www.uptodate.comThe History of ADHD and Its Treatments, https://www.additudemag.com/history-of-adhd/Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. 

Contributor: Travis Barlock, MD Educational Pearls: Wheezing is classically heard in asthma and COPD, but it can be the result of a wide range of processes that cause airflow limitation Narrowed bronchioles lead to turbulent airflow → creates the wheezing Crackles (rales) suggest pulmonary edema which is often due to heart failure Approximately 35% of heart failure patients have bronchial edema, which can also produce wheezing COPD and heart failure can coexist in a patient, and both of these diseases can cause wheezing It's vital to differentiate whether the wheezing is due to the patient's COPD or their heart failure because the treatment differs Diagnosing wheezing due to heart failure (cardiac asthma): Symptoms: orthopnea, paroxysmal nocturnal dyspnea Diagnostic tools: bedside ultrasound Treatment: diuresis and BiPAP for respiratory support Not all wheezing is asthma Consider heart failure in the differential and tailor treatment accordingly References 1. Buckner K. Cardiac asthma. Immunol Allergy Clin North Am. 2013 Feb;33(1):35-44. doi: 10.1016/j.iac.2012.10.012. Epub 2012 Dec 23. PMID: 23337063. 2. Hollingsworth HM. Wheezing and stridor. Clin Chest Med. 1987 Jun;8(2):231-40. PMID: 3304813. Summarized by Meg Joyce, MS1 | Edited by Meg Joyce & Jorge Chalit, OMS3 Donate: https://emergencymedicalminute.org/donate/  

About this episode: Diagnoses of autism are on the rise, but is this the result of more children being affected by the condition, or is more of a consequence of broader criteria and more screening? In this episode: a look at a new study about the number of children diagnosed with autism and what this research shows—and doesn't show. Guest: Dr. Christine Ladd-Acosta is an autism researcher and vice-director of the Wendy Klag Center for Autism and Developmental Disabilities. She is the lead Maryland investigator on a national study about the rate of autism. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Prevalence and Early Identification of Autism Spectrum Disorder Among Children Aged 4 and 8 Years - Autism and Developmental Disabilities Monitoring Network, 16 Sites, United States 2022—CDC's MMWR RFK Jr.'s autism study to amass medical records of many Americans—CBS News The NIH-Funded Autism Study Hoping to Pinpoint Gene-Environmental Interplay—Public Health On Call (March 2025) Vaccines Don't Cause Autism. Why Do Some People Think They Do?—Hopkins Bloomberg Public Health Discovering How Environment Affects Autism—Hopkins Bloomberg Public Health Magazine (2023) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.